Cologne, Germany

Rolf Coblenz


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1983-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rolf Coblenz: Innovator in Reaction Mixture Production

Introduction

Rolf Coblenz is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of reaction mixture production, particularly in the area of polyurethane forming components. With a total of 2 patents to his name, Coblenz has developed innovative methods and devices that enhance the efficiency and effectiveness of production processes.

Latest Patents

Coblenz's latest patents focus on methods and devices for producing reaction mixtures from flowable foam-forming or solid-forming components. The first patent describes a method where the quantity to be conveyed is preselected, and the injection pressure is also predetermined. During the circulation and mixing process, these values are compared with actual measurements to ensure accuracy. This invention is particularly useful for filling cavities and producing molded articles in molds. The second patent reiterates similar principles, emphasizing the continuous conveyance and mixing of components to achieve optimal results in production.

Career Highlights

Rolf Coblenz is associated with Bayer Aktiengesellschaft, a leading company in the chemical and pharmaceutical industry. His work at Bayer has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in production technology.

Collaborations

Coblenz has collaborated with notable colleagues such as Klaus Schulte and Wilfried Ebeling. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Rolf Coblenz's contributions to the field of reaction mixture production demonstrate his commitment to innovation and excellence. His patents reflect a deep understanding of the complexities involved in manufacturing processes, making him a valuable asset to Bayer Aktiengesellschaft and the industry as a whole.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…